Audience-funded nonprofit news
Next Up:
0:00
0:00
-
Listen Listen
Health
Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the makers of Wegovy and Mounjaro are seeking FDA approval for tablets.
Sponsored message
More Stories
-
The number keeps growing as regulators move to impose workplace safety measures.
-
Multiple organ failure, heart attack and kidney failure are the primary ways people die in extreme heat. Read on to find out how to stay safe in the heat wave.
-
California’s experimental new program targets methamphetamine addiction by rewarding patients with gift cards for negative drug tests.
-
More people are testing positive for COVID
-
State officials have promised to boost funding for California’s Medicaid program by $11.1 billion starting next year, with most of that money earmarked for higher payments to doctors, hospitals, and other providers. But the details have yet to be worked out, and powerful health industry groups are jockeying for positions.
-
All the information available so far on newly FDA-approved over-the-counter birth control.
-
A new ban on flavored tobacco products is accelerating a decline in nicotine tax revenue that funds California’s early childhood services. Some programs are already making cuts.
-
The painful rash can take weeks to develop.
-
From convenience stores to online, the tablet "will be an available option for millions of people in the United States," the director of the FDA's Center for Drug Evaluation and Research says.
-
Here’s how to cool off without breaking the bank.
-
Check the backseat. Every time.
-
When's the right time to start your child with a phone? Is 12 too young? Here's what a professional screen time consultant tells parents about the risks kids face online.
